Jennerex and Lee’s Pharmaceutical Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in Combination with Irinotecanin Patients with Metastatic Colorectal Cancer 2012.03.21

 
 
  Download  


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD